Advertisement
U.S. Markets closed

Sandoz Group AG (SDZNY)

OTC Markets OTCQX - OTC Markets OTCQX Delayed Price. Currency in USD
43.73-0.55 (-1.24%)
At close: 02:37PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close44.28
Open43.86
Bid43.76 x 40000
Ask43.90 x 27000
Day's Range43.73 - 43.87
52 Week Range25.71 - 44.99
Volume733
Avg. Volume39,768
Market Cap18.854B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.02
Earnings DateAug 08, 2024
Forward Dividend & Yield0.50 (1.12%)
Ex-Dividend DateMay 03, 2024
1y Target EstN/A
  • GlobeNewswire

    Sandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolio

    MEDIA RELEASE First FDA-approved abbreviated new drug application (ANDA) to reference medicineSingle-dose 100 mg vial for intravenous use, approved for metastatic breast cancerLaunch expected to be near-term growth driver in US market Princeton, NJ, October 11, 2024 – Sandoz, the global leader in generic and biosimilar medicines, today announced that it has launched a generic paclitaxel formulation in the US, the first generic to its reference medicine to be approved by the US Food and Drug Admi

  • The Wall Street Journal

    Health Care Roundup: Market Talk

    Read about Bausch + Lomb, Sandoz Group and more in the latest Market Talks covering the Health Care sector.